Journal
AMERICAN JOURNAL OF PATHOLOGY
Volume 162, Issue 6, Pages 2005-2017Publisher
ELSEVIER SCIENCE INC
DOI: 10.1016/S0002-9440(10)64333-7
Keywords
-
Categories
Funding
- NHLBI NIH HHS [R01 HL069057-01A1, R01 HL069057] Funding Source: Medline
- NIAID NIH HHS [AI42117] Funding Source: Medline
Ask authors/readers for more resources
Febrile-range hyperthermia (FRH) improves survival in experimental infections by accelerating pathogen clearance, but may also increase collateral tissue injury. We hypothesized that FRH would worsen the outcome of inflammation stimulated by a non-replicating agonist and tested this hypothesis in a murine model of pulmonary oxygen toxicity. Using a conscious, temperature-controlled mouse model, we showed that maintaining a core temperature at FRH (39degreesC to 40degreesC) rather than at euthermic levels (36.5degreesC to 37degreesC) during hyperoxia exposure accelerated lethal pulmonary vascular endothelial injury, reduced the inspired oxygen threshold for lethality, induced expression of granulocyte-colony stimulating factor, and expanded the circulating neutrophil pool. in these same mice, FRH augmented pulmonary expression of the ELR+ CXC chemokines, KC and LPS-induced CXC chemokine, enhanced recruitment of neutrophils, and changed the histological pattern of lung injury to a neutrophilic interstitial pneumonitis. Immunoblockade of CXC receptor-2 abrogated neutrophil recruitment, reduced pulmonary vascular injury, and delayed death. These combined data demonstrate that FRH may enlist distinct mediators and effector cells to profoundly shift the host response to a defined injurious stimulus, in part by augmenting delivery of neutrophils to sites of inflammation, such as may occur in infections. In certain conditions, such as in the hyperoxic lung, this process may be deleterious. (Am J Pathol 2003, 162:2005-2017)
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available